Provided by Tiger Trade Technology Pte. Ltd.

NovoCure

15.48
-0.1500-0.96%
Volume:662.84K
Turnover:10.30M
Market Cap:1.80B
PE:-11.83
High:16.07
Open:15.26
Low:15.10
Close:15.63
52wk High:21.45
52wk Low:9.82
Shares:116.45M
Float Shares:96.42M
Volume Ratio:0.77
T/O Rate:0.69%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.3082
EPS(LYR):-1.2221
ROE:-43.22%
ROA:-9.26%
PB:5.33
PE(LYR):-12.67

Loading ...

Novocure is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
Jul 24

Novocure price target raised to $52 from $46 at H.C. Wainwright

TIPRANKS
·
Jul 24

Novocure Shares Rise After Co Boosts FY26 Revenue Guidance

Dow Jones
·
Jul 23

Novocure Ltd Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Jul 23

Utah Medical Q2 Revenue Falls 14% on Lost Customers

Reuters
·
Jul 23

NovoCure's Q2 Net Loss Narrows, Revenue Rises; 2026 Revenue Guidance Raised

MT Newswires Live
·
Jul 23

Novocure Q2 Revenue Beats, Lifts 2026 Outlook

Reuters
·
Jul 23

Novocure Q2 Revenue USD 183.584 Million Vs. IBES Estimate USD 172.4 Million

Reuters
·
Jul 23

GUIDANCE: (NVCR) NovoCure Expects Full Year 2026 Revenue Range $710M - $725M, vs. FactSet Est of $708.7M

MT Newswires Live
·
Jul 23

Earnings Flash (NVCR) NovoCure Posts Q2 Loss $0.13 per Share, vs. FactSet Est of $0.33 Loss

MT Newswires Live
·
Jul 23

NovoCure Q2 EPS $(0.13) Beats $(0.33) Estimate, Sales $183.584M Beat $172.437M Estimate

Benzinga Earnings
·
Jul 23

Novocure Q2 FY26 Net Loss Narrows to USD 15.66 Million; Revenue Rises 16% to USD 183.58 Million

Reuters
·
Jul 23

Novocure Q2 EPS USD -0.13

THOMSON REUTERS
·
Jul 23

Novocure Q2 Pretax Profit USD -12.452 Million

THOMSON REUTERS
·
Jul 23

Novocure Q2 Revenue USD 183.584 Million VS. Ibes Estimate USD 172.4 Million

THOMSON REUTERS
·
Jul 23

Novocure Reports Second Quarter 2026 Financial Results

THOMSON REUTERS
·
Jul 23

Earning Preview: NovoCure revenue is expected to increase by 12.00%, institutions lean cautious on near-term profitability

Earnings Agent
·
Jul 17

Analysts Have Conflicting Sentiments on These Healthcare Companies: COMPASS Pathways (CMPS), NovoCure (NVCR) and Bristol-Myers Squibb (BMY)

TIPRANKS
·
Jul 13

Novocure Price Target Announced at $17.00/share by JP Morgan

Dow Jones
·
Jul 13

J.P. Morgan Sticks to Its Hold Rating for NovoCure (NVCR)

TIPRANKS
·
Jul 13